Calcium-induced activation and truncation of promatrix metalloproteinase-9 linked to the core protein of chondroitin sulfate proteoglycans

European Journal of Biochemistry

Volumn 270, Issue 19, 2003, Pages 3996-4007

  Winberg, Jan Olof ^a   Berg, Eli ^a   Kolset, Svein O ^b   Uhlin Hansen, Lars ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Activation; Calcium; Gelatinase B; MMP 9; Proteoglycan

Indexed keywords

1,10 PHENANTHROLINE; ACETIC ACID DERIVATIVE; ACID PROTEINASE; AMINOPHENYLMERCURIC ACETATE; CALCIUM; CALCIUM CHLORIDE; CORE PROTEIN; DIMER; EDETIC ACID; GELATINASE B; MAGNESIUM CHLORIDE; MATRIX METALLOPROTEINASE INHIBITOR; METAL DERIVATIVE; MONOMER; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; SERINE; SODIUM CHLORIDE; THIOL; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; ZINC CHLORIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CHEMICAL REACTION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; ELECTRICITY; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL LINE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REACTION ANALYSIS;

ANIMALS; CALCIUM; CALCIUM CHLORIDE; COLLAGENASES; DIMERIZATION; ENZYME ACTIVATION; ENZYME PRECURSORS; HUMANS; MACROMOLECULAR SUBSTANCES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MOLECULAR WEIGHT; PHENYLMERCURIC ACETATE; PROTEOCHONDROITIN SULFATES; TUMOR CELLS, CULTURED;

EID: 0141704099     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2003.03788.x     Document Type: Article

References (50)

1. Nagase, H. & Woessner, J.F. Jr (1999) Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
2. Johansson, N., Ahonen, M. & Kahari, V.M. (2000) Matrix metalloproteinases in tumor invasion. Cell Mol. Life Sci. 57, 5-15.
3. Birkedal-Hansen, H., Moore, W.G., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A. & Engler, J.A. (1993) Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Medical 4, 197-250.
4. Coussens, L.M. & Werb, Z. (1996) Matrix metalloproteinases and the development of cancer. Chem. Biol. 3, 895-904.
5. Machein, U. & Conca, W. (1997) Expression of several matrix metalloproteinase genes in human monocytic cells. Adv. Exp Med. Biol. 421, 247-251.
6. Shapiro, S.D., Campbell, E.J., Senior, R.M. & Welgus, H.G. (1991) Proteinases secreted by human mononuclear phagocytes. J. Rheumatol. Suppl. 27, 95-98.
7. Welgus, H.G., Campbell, E.J., Cury, J.D., Eisen, A.Z., Senior, R.M., Wilhelm, S.M. & Goldberg, G.I. (1990) Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86, 1496-1502.
8. Welgus, H.G., Senior, R.M., Parks, W.C., Kahn, A.J., Ley, T.J., Shapiro, S.D. & Campbell, E.J. (1992) Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation. Matrix Suppl. 1, 363-367.
9. Gibbs, D.F., Warner, R.L., Weiss, S.J., Johnson, K.J. & Varani, J. (1999) Characterization of matrix metalloproteinases produced by rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 20, 1136-1144.
10. Murphy, G. & Reynolds, J.J. (1993) Extracellular matrix degradation. In Connective Tissue and its Heritable Disorders. Molecular, Genetic and Medical Aspects (Royce, P.M. & Steinman, B., eds), pp. 287-316. Wiley-Liss Inc, New York.
11. Liu, Z., Zhou, X., Shapiro, S.D., Shipley, J.M., Twining, S.S., Diaz, L.A., Senior, R.M. & Werb, Z. (2000) The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102, 647-655.
12. Manes, S., Llorente, M., Lacalle, R.A., Gomez-Mouton, C., Kremer, L., Mira, E. & Martinez, A.C. (1999) The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells. J. Biol. Chem. 274, 6935-6945.
13. Nagase, H. (1997) Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151-160.
14. Matrisian, L.M. (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6, 121-125.
15. Woessner, J.F. Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154.
16. Van Wart, H.E. & Birkedal-Hansen, H. (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl Acad. Sci. USA 87, 5578-5582.
17. Nagase, H., Suzuki, K., Morodomi, T., Enghild, J.J. & Salvesen, G. (1992) Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Matrix Suppl. 1, 237-244.
18. Liotta, L.A. & Stetler-Stevenson, W.G. (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 51, 5054s-5059s.
19. Hibbs, M.S., Hasty, K.A., Seyer, J.M., Kang, A.H. & Mainardi, C.L. (1985) Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260, 2493-2500.
20. Triebel, S., Blaser, J., Reinke, H. & Tschesche, H. (1992) A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett. 314, 386-388.
21. Kjeldsen, L., Johnsen, A.H., Sengelov, H. & Borregaard, N. (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268, 10425-10432.
22. Olson, M.W., Bernardo, M.M., Pietila, M., Gervasi, D.C., Toth, M., Kotra, LP., Massova, I., Mobashery, S. & Fridman, R. (2000) Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9: differential rates for activation by stromelysin 1. J. Biol. Chem. 275, 2661-2668.
23. Winberg, J.O., Kolset, S.O., Berg, E. & Uhlin-Hansen, L. (2000) Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J. Mol. Biol. 304, 669-680.
24. Cha, H., Kopetzki, E., Huber, R., Lanzendorfer, M. & Brandstetter, H. (2002) Structural basis of the adaptive molecular recognition by MMP9. J. Mol. Biol. 320, 1065-1079.
25. Kjellen, L. & Lindahl, U. (1991) Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60, 443-475.
26. Uhlin-Hansen, L., Wik, T., Kjellen, L., Berg, E., Forsdahl, F. & Kolset, S.O. (1993) Proteoglycan metabolism in normal and inflammatory human macrophages. Blood 82, 2880-2889.
27. Øynebråten, I., Hansen, B., Smedsrød, B. & Uhlin-Hansen, L. (2000) Serglycin secreted by leucocytes is efficiently eliminated from the circulation by sinusoidal scavanger endothelial cells in the liver. J. Leukoc. Biol. 67, 183-188.
28. Butler, G.S., Butler, M.J., Atkinson, S.J., Will, H., Tamura, T., van Westrum, S.S., Crabbe, T., Clements, J., d'Ortho, M.P. & Murphy, G. (1998) The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A: a kinetic study. J. Biol. Chem. 273, 871-880.
29. 2+ for fibronectin and heparin binding: binding properties of recombinant gelatinase AC domain to extracellular matrix and basement membrane components. J. Biol. Chem. 272, 7473-7481.
30. Housley, T.J., Baumann, A.P., Braun, I.D., Davis, G., Seperack, P.K. & Wilhelm, S.M. (1993) Recombinant Chinese hamster ovary cell matrix metalloprotease-3 (MMP-3, stromelysin-1): role of calcium in promatrix metalloprotease-3 (pro-MMP-3, prostromelysin-1) activation and thermostability of the low mass catalytic domain of MMP-3. J. Biol. Chem. 268, 4481-4487.
31. 2+ in the action of mammalian collagenases. Arch. Biochem. Biophys. 173, 355-361.
32. 2+ in activation and catalysis. J. Biol. Chem. 270, 18563-18569.
33. 2+-dependent activity of human neutrophil gelatinase B. J. Biol. Chem. 271, 14308-14315.
34. Carrino, D.A., Arias, J.L. & Caplan, A.I. (1991) A spectrophotometric modification of a sensitive densitometric Safranin O assay for glycosaminoglycans. Biochem. Int. 24, 485-495.
35. Makowski, G.S. & Ramsby, M.L. (1996) Calibrating gelatin zymograms with human gelatinase standards. Anal. Biochem. 236, 353-356.
36. Winberg, J.O. & Gedde-Dahl, T. Jr (1992) Epidermolysis bullosa simplex: expression of gelatinase activity in cultured human skin fibroblasts. Biochem. Genet. 30, 401-420.
37. Winberg, J.O. & Gedde-Dahl, T. Jr (1986) Gelatinase expression in generalized epidermolysis bullosa simplex fibroblasts. J. Invest. Dermatol. 87, 326-329.
38. Murphy, G. & Crabbe, T. (1995) Gelatinases A and B. Methods Enzymol. 248, 470-484.
39. Nagase, H., Itoh, Y. & Binner, S. (1994) Interaction of alpha 2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms. Ann. NY Acad. Sci. 732, 294-302.
40. Kolset, S.O., Mann, D.M., Uhlin-Hansen, L., Winberg, J.O. & Ruoslahti, E. (1996) Serglycin-binding proteins in activated macrophages and platelets. J. Leukoc. Biol. 59, 545-554.
41. Yu, W.H. & Woessner, J.F. Jr (2000) Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem. 275, 4183-4191.
42. Sopata, I. & Maslinski, S. (1991) Activation of the latent human neutrophil gelatinase by urea. Acta Biochim. Pol. 38, 67-70.
43. Triebel, S., Blaser, J., Reinke, H., Knauper, V. & Tschesche, H. (1992) Mercurial activation of human PMN leucocyte type IV procollagenase (gelatinase). FEBS Lett. 298, 280-284.
44. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K. & Hayakawa, T. (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267, 21712-21719.
45. Chen, L.C., Noelken, M.E. & Nagase, H. (1993) Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1). Biochemistry 32, 10289-10295.
46. Galazka, G., Windsor, L.J., Birkedal-Hansen, H. & Engler, J.A. (1996) APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide. Biochemistry 35, 11221-11227.
47. Galazka, G., Windsor, L.J., Birkedal-Hansen, H. & Engler, J.A. (1999) Spontaneous propeptide processing of mini-stromelysin-1 mutants blocked by APMA (4-aminophenyl) mercuric acetate). Biochemistry 38, 1316-1322.
48. Suzuki, K., Kan, C.C., Hung, W., Gehring, M.R., Brew, K. & Nagase, H. (1998) Expression of human pro-matrix metalloproteinase 3 that lacks the N-terminal 34 residues in Escherichia coli: autoactivation and interaction with tissue inhibitor of metalloproteinase 1 (TIMP-1). Biol. Chem. 379, 185-191.
49. Tschesche, H., Zolzer, V., Triebel, S. & Bartsch, S. (2001) The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. Eur. J. Biochem. 268, 1918-1928.
50. Carlsson, S.R. (1993) Isolation and characterization of glycoproteins. In Glycobiology a Practical Approach (Fukuda, M. & Kobata, A., eds), pp. 1-26. IRL Press, Oxford.